Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ICRF 154

Known as: ICRF-154 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
ICRF-154 and bimolane have been used for the treatment of cancer, psoriasis, and uveitis in humans. Previous reports have… Expand
Is this relevant?
2005
2005
BackgroundAnticancer bisdioxopiperazines, including ICRF-154, razoxane (Raz, ICRF-159) and ICRF-193, are a family of anticancer… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2001
2001
The bisdioxopiperazines ICRF-187 (dexrazoxane), ICRF-193, and ICRF-154 are catalytic noncleavable complex-forming inhibitors of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
2000
2000
This study investigates the solution thermodynamics of the iron complexes of dexrazoxane (ICRF-187, (+)-1,2-bis(3,5… Expand
Is this relevant?
1997
1997
A Chinese hamster ovary (CHO) cell line highly resistant to the non-cleavable complex-forming topoisomerase II inhibitor… Expand
Is this relevant?
1997
1997
Histologic and biochemical studies were carried out to compare the protective activity of various bisdiketopiperazines against… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1996
1996
Etoposide is a topoisomerase II inhibitor that induces DNA cleavable complex and has been used as an antitumor drug. We isolated… Expand
Is this relevant?
1995
1995
A series of twelve structurally related bisdioxopiperazines that included ICRF-187 (dexrazoxane), ICRF-159 (razoxane), ICRF-193… Expand
Is this relevant?
Highly Cited
1991
Highly Cited
1991
In the accompanying paper (K. Tanabe, Y. Ikegami, R. Ishida, and T. Andoh, Cancer Res., 51: 4903-4908, 1991), we showed that ICRF… Expand
Is this relevant?
Highly Cited
1991
Highly Cited
1991
Several recently developed derivatives of bis(2,6-dioxopiperazine) have been shown to be new antitumor agents and are currently… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?